Wednesday, February 20, 2019
Alita: Battle Angel [{2019}] VIDEO QUALITY PRO [FuLL_Movie]
https://www.twitch.tv/videos/383257529
https://www.twitch.tv/videos/383257530
https://www.twitch.tv/videos/383257531
https://www.twitch.tv/videos/383257532
https://www.twitch.tv/videos/383257533
https://www.twitch.tv/videos/383257534
https://www.twitch.tv/videos/383257535
https://www.twitch.tv/videos/383257536
https://www.twitch.tv/videos/383257537
https://www.twitch.tv/videos/383257538
Alita: Battle Angel is a 2019 American cyberpunk[7] action film based on Yukito Kishiro's manga series Gunnm, also known as Battle Angel Alita. Directed by Robert Rodriguez, the film is written by James Cameron and Laeta Kalogridis produced by Cameron and Jon Landau. Rosa Salazar stars as the titular Alita, a cyborg who sets out to learn about her past after she awakens in a new body with no memory of who she is. Christoph Waltz, Jennifer Connelly, Mahershala Ali, Ed Skrein, Jackie Earle Haley and Keean Johnson also star in supporting roles.
Originally announced in 2003, production on the release of the film was repeatedly delayed due to Cameron's work on Avatar and its sequels. After years of languishing in development hell, Rodriguez was announced as the film's director in April 2016, with Salazar being cast the following month. Principal photography began in Austin, Texas, in October 2016, lasting through February 2017.
Alita: Battle Angel premiered at the Odeon Leicester Square on January 31, 2019, and was released in the United States on February 14, 2019 by 20th Century Fox in Real D 3D, Dolby Cinema and IMAX 3D formats. The film has grossed over $140 million worldwide, making it the sixth highest-grossing film of 2019. It received mixed reviews from critics, with praise for its visual effects, action sequences and Salazar's performance while criticism was directed at the "muddled" screenplay and the set-up of sequels.[8] In contrast, the film received a more positive response from audiences.[5]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment